top of page

Lymphangiogram

Image by Harry Singh

A lymphangiogram is employed as a diagnostic tool to identify and localize lymphatic leaks, which occur when lymphatic vessels are damaged or disrupted, leading to the leakage of lymphatic fluid into surrounding tissues. The primary lymphatic vessel, known as the thoracic duct, transports lymphatic fluid from tissues and organs like the liver and intestinal tract back into the bloodstream. Damage to this duct, congenital anomalies, or elevated venous pressures may lead to disruptions in lymphatic flow, causing leakage of lymphatic fluid into the chest, abdomen, or other bodily cavities. Pre-diagnostic tests such as CT or dynamic contrast MR lymphangiography are used to diagnose a lymphatic leak.

 

During a lymphangiogram procedure, a contrast agent is injected into the lymphatic vessels, allowing visualization of the lymphatic system using fluoroscopy. Once a lymphatic leak is identified, a lymphatic embolization can be performed.  This is a minimally invasive procedure aimed at blocking or sealing off the leaking lymphatic vessels to restore normal lymphatic flow and prevent further leakage.

In lymphatic embolization, embolic agents are introduced into the affected lymphatic vessels to occlude or block them, thereby stemming the flow of lymphatic fluid through the leak. These embolic agents can include substances such as ethyl vinyl alcohol copolymer (Onyx), glue (n-butyl cyanoacrylate), or coils, which are delivered via catheter-based techniques under imaging guidance. Once deployed, these embolic agents create a physical barrier within the lymphatic vessels, effectively sealing off the leak and promoting the resolution of symptoms associated with the lymphatic leak.

Lymphatic embolization has demonstrated promising results in the treatment of various conditions associated with lymphatic leaks, including chylous ascites, chylothorax, lymphedema, and lymphatic malformations.

A&I Protocol

Percutaneous ultrasound-guided access:

 

  • Seldinger technique is used to gain access into the right and/or left femoral or inguinal lymph node (near the groin region) using ultrasound-guidance and small gauge cannulas (e.g. 23G).

  • Fluoroscopy and injection of contrast media is used to determine whether the lymphatic system has been accessed correctly.

  • Flow of contrast will be slow and different visually to an artery or vein for example.

  • Once access is confirmed to be in the lymphatic system, lymphatic embolization can proceed with the embolic of choice (e.g. Lipiodol).

  • The cannula is secured externally, and a three-way tap may be attached prior to injecting the embolic.

  • Slow injection by the interventional radiologist of the embolic through the cannula and use of fluoroscopy to demonstrate the contrast flow through the lymphatic system towards the thoracic duct (embolization endpoint).

  • When embolization endpoint is attained, a final post-lymphatic embolization fluoroscopy image is acquired, and the cannula access is removed. A cone-beam CT can sometimes be used to show the lymphatic embolization.

  • The same steps are repeated if there is a lymphatic leak on the contralateral side.

Lymphangiogram showing embolization using lipiodol.

References

  1. Imaging Modalities for Evaluating Lymphedema - PubMed [Internet]. [cited 2024 May 15]. Available from: https://pubmed.ncbi.nlm.nih.gov/38004065/

  2. Rockson SG. Extending Diagnostic Imaging Accuracy in Lymphedema. Lymphat Res Biol. 2021 Dec;19(6):515–6. 

  3. Kariya S, Komemushi A, Nakatani M, Yoshida R, Kono Y, Tanigawa N. Intranodal lymphangiogram: technical aspects and findings. Cardiovasc Intervent Radiol. 2014 Dec;37(6):1606–10. 

     

bottom of page